CDK4/6 inhibition in early and metastatic breast cancer: A review-Reference-Cited by-全球学者库

CDK4/6 inhibition in early and metastatic breast cancer: A review

Published:2017-11 Issue: Volume:60 Page:130-138
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

de Groot A.F.,Kuijpers C.J.,Kroep J.R.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference38 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Ferlay J, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Globocan 2012 v1.0 [cited 2017 Jun. 14]; Available from: http://globocan.iarc.fr.

3. National Cancer Institute. SEER Cancer Statistics Factsheets: Breast Cancer. [cited 2017 Feb 1]; Available from: https://seer.cancer.gov/statfacts/html/breast.html.

4. Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study;Gong;Sci Rep,2017

5. Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers;Finn;Breast Cancer Res,2016

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Rare Cause of Duodenal Ulcer;Gastroenterology;2023-11

2. Clinical Experience with Abemaciclib in Patients Previously Treated with Another CDK 4/6 Inhibitor in a Tertiary Hospital: A Case Series Study;Cancers;2023-09-07

3. Management of Breast Cancer;PET/CT in Breast Cancer;2023

4. A rapid reduction in tumor size by cyclin-dependent kinase inhibition in hormone receptor-positive postpartum breast cancer: a case report of two patients and a review of the literature;Annals of Translational Medicine;2022-12

5. Translational Strategies to Target Metastatic Bone Disease;Cells;2022-04-12